Exact Mass: 590.4236

Ubiquinone 6

C39H58O4 (590.4335)

Ubiquinone-6 is a member of the chemical class known as Polyprenylbenzoquinones. These are compounds containing a polyisoprene chain attached to a quinone at the second ring position. Ubiquione-6 has just 6 isoprene units. Normally in humans it has 10. Ubiquinone-6 is an intermediate in the synthesis of Ubiquionone 10. It is an endogenouse compound but it has also been isolated from foods containing bakers yeast. Ubiquionone 10 (CoQ10) is involved in cellular respiration. It is fat-soluble and is therefore mobile in cellular membranes; it plays a unique role in the electron transport chain (ETC). In the inner bacterial membrane, electrons from NADH and succinate pass through the ETC to the oxygen, which is then reduced to water. The transfer of electrons through ETC results in the pumping of H+ across the membrane creating a proton gradient across the membrane, which is used by ATP synthase (located on the membrane) to generate ATP. Isolated from bakers yeast (Saccharomyces cerevisiae)

Saringosterol 3-glucoside

C35H58O7 (590.4182)

Saringosterol 3-glucoside is found in pulses. Saringosterol 3-glucoside is a constituent of immature French bean seeds (Phaseolus vulgaris)

Melilotoside A

C35H58O7 (590.4182)

Melilotoside A is found in herbs and spices. Melilotoside A is a constituent of Melilotus albus (white melilot). Constituent of Melilotus albus (white melilot). Melilotoside A is found in herbs and spices and pulses.

Feruloyl-beta-sitosterol

C39H58O4 (590.4335)

Feruloyl-beta-sitosterol is found in cereals and cereal products. Feruloyl-beta-sitosterol is isolated from rice bran oil (Oryza sativa).

Hebevinoside IX

C35H58O7 (590.4182)

Toxic constituent of the toxic mushroom Hebeloma vinosophyllum. Hebevinoside IX is found in mushrooms. Hebevinoside IX is found in mushrooms. Toxic constituent of the toxic mushroom Hebeloma vinosophyllu

PA(14:1(9Z)/14:0)

C31H59O8P (590.3947)

PA(14:1(9Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/14:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

DG(12:0/PGJ2/0:0)

C35H58O7 (590.4182)

DG(12:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/12:0/0:0)

C35H58O7 (590.4182)

DG(PGJ2/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/PGJ2)

C35H58O7 (590.4182)

DG(12:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/0:0/12:0)

C35H58O7 (590.4182)

DG(PGJ2/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C36H62O6 (590.4546)

DG(13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C36H62O6 (590.4546)

DG(13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C36H62O6 (590.4546)

DG(13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C36H62O6 (590.4546)

DG(13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C36H62O6 (590.4546)

DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C36H62O6 (590.4546)

DG(13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C36H62O6 (590.4546)

DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0)

C36H62O6 (590.4546)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C36H62O6 (590.4546)

DG(a-13:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-13:0)

C36H62O6 (590.4546)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/PGJ2/0:0)

C35H58O7 (590.4182)

DG(i-12:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/i-12:0/0:0)

C35H58O7 (590.4182)

DG(PGJ2/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/PGJ2)

C35H58O7 (590.4182)

DG(i-12:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/0:0/i-12:0)

C35H58O7 (590.4182)

DG(PGJ2/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C36H62O6 (590.4546)

DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C36H62O6 (590.4546)

DG(i-13:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C36H62O6 (590.4546)

DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C36H62O6 (590.4546)

DG(i-13:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C36H62O6 (590.4546)

DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C36H62O6 (590.4546)

DG(i-13:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-13:0)

C36H62O6 (590.4546)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C36H62O6 (590.4546)

DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0)

C36H62O6 (590.4546)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

Schottenol 3-ferulate

C39H58O4 (590.4335)

Schottenol 3-ferulate is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Schottenol 3-ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Schottenol 3-ferulate can be found in corn, which makes schottenol 3-ferulate a potential biomarker for the consumption of this food product.

Buxmicrophylline F

C37H54N2O4 (590.4083)

Staphimine

C41H54N2O (590.4236)

3beta-[(m-methoxybenzoyl)oxy]urs-12-en-28-oic acid

C38H54O5 (590.3971)

3beta-O-cis-p-coumaroylmonogynol A

C39H58O4 (590.4335)

3alpha-acetoxyl-21S-methoxy-25-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin J

C35H58O7 (590.4182)

7-oxositosteryl-beta-D-glucopyranoside|7-Oxositosteryl-??-O-glucopyranoside

C35H58O7 (590.4182)

FT-0674605

C35H58O7 (590.4182)

21-(3-15399-42-5Methylbutanoyl)---12-Oleanene-3,16,21,22,23,28-hexol|21-(3-Methylbutanoyl) -(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,23,28-hexol

C35H58O7 (590.4182)

dammarenediol II 3-O-p-coumarate

C39H58O4 (590.4335)

Giganteumgenin H|Giganteumgenin K

C35H58O7 (590.4182)

Giganteumgenin G

C35H58O7 (590.4182)

Alloxanthin

C42H54O2 (590.4124)

3beta-hydroxy-27-benzoyloxylup-20(29)-en-28-oic acid methyl ester

C38H54O5 (590.3971)

Giganteumgenin K

C35H58O7 (590.4182)

(3beta,16beta,21beta,22alpha)-3,16,22,23,28-pentahydroxyolean-12-en-21-yl (2S)-2-methylbutanoate

C35H58O7 (590.4182)

terminamine B

C33H54N2O7 (590.3931)

chisopanin N

C35H58O7 (590.4182)

3-beta,15-alpha,23,28-tetrahydroxyolean-12-en-3-O-alpha-L-arabinofuranoside

C35H58O7 (590.4182)

haliclioc acid A

C38H54O5 (590.3971)

22alpha-angeloyloxy-3beta,15alpha,16alpha,28-tetrahydroxyolean-12-ene

C35H58O7 (590.4182)

haliclioc acid B

C38H54O5 (590.3971)

feroniellide D

C35H58O7 (590.4182)

C35H58O7

C35H58O7 (590.4182)

Delta7-sitosterol trans-ferulate|schottenol ferulate

C39H58O4 (590.4335)

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocoumarate|21??-Hydroxyserrat-14-en-3??-yl p-dihydrocoumarate

C39H58O4 (590.4335)

C38H54O5

C38H54O5 (590.3971)

(22R)-stigmasta-7,9(11)-dien-22alpha-ol-3beta-O-beta-D-galactopyranoside

C35H58O7 (590.4182)

C43H58O

C43H58O (590.4487)

Methyl-2alpha-benzoyloxy-3beta-hydroxyolean-12-en-28-oat

C38H54O5 (590.3971)

beta-sitosteryl glucuronate|stigmast-5-en-3beta-yl glucuronate

C35H58O7 (590.4182)

Descladinose Azithromycin

C30H58N2O9 (590.4142)

DescladinoseAzithromycin

C30H58N2O9 (590.4142)

PA(12:0/16:1(9Z))

C31H59O8P (590.3947)

PA(13:0/15:1(9Z))

C31H59O8P (590.3947)

PA(14:0/14:1(9Z))

C31H59O8P (590.3947)

PA(14:1(9Z)/14:0)

C31H59O8P (590.3947)

PA(15:1(9Z)/13:0)

C31H59O8P (590.3947)

PA(16:1(9Z)/12:0)

C31H59O8P (590.3947)

PA(P-16:0/13:0)

C32H63O7P (590.4311)

Saringosterol 3-glucoside

C35H58O7 (590.4182)

Hebevinoside IX

C35H58O7 (590.4182)

Sitosterol ferulate

C39H58O4 (590.4335)

Melilotoside A

C35H58O7 (590.4182)

PA 28:1

C31H59O8P (590.3947)

PA O-29:1

C32H63O7P (590.4311)

Coenzyme Q6

C39H58O4 (590.4335)

CHOLESTERYL 9-ANTHRACENECARBOXYLATE

C42H54O2 (590.4124)

Titanium(III) chloride-aluminum chloride

AlCl12Ti3 (590.4516)

N-lauroyl-D-erythro-sphingosyl phosphoethanolamine (C17 base)

C31H63N2O6P (590.4424)

Dimyristoyl phosphatidic acid

C31H59O8P-2 (590.3947)

Schottenol ferulate

C39H58O4 (590.4335)

DG(12:0/PGJ2/0:0)

C35H58O7 (590.4182)

DG(PGJ2/12:0/0:0)

C35H58O7 (590.4182)

DG(12:0/0:0/PGJ2)

C35H58O7 (590.4182)

DG(PGJ2/0:0/12:0)

C35H58O7 (590.4182)

DG(i-12:0/PGJ2/0:0)

C35H58O7 (590.4182)

DG(PGJ2/i-12:0/0:0)

C35H58O7 (590.4182)

DG(i-12:0/0:0/PGJ2)

C35H58O7 (590.4182)

DG(PGJ2/0:0/i-12:0)

C35H58O7 (590.4182)

N-lauroyl-D-D-erythro-heptadecasphingosyl phosphoethanolamine

C31H63N2O6P (590.4424)

(2S,3R,4S,5S)-2-[[(3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]oxane-3,4,5-triol

C35H58O7 (590.4182)

cholesteryl 6-O-acetyl-beta-D-galactoside

C35H58O7 (590.4182)

A cholesteryl 6-O-acyl-beta-D-galactoside having acetyl as the 6-O-acyl group.

1,2-Dimyrsitoylphosphatidate(2-)

C31H59O8P-2 (590.3947)

(2S,3R,4S,5R)-2-[[(9R,10R,13R,14S,16R,17R)-7,16-dihydroxy-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

C35H58O7 (590.4182)

NAGlySer 16:4/12:0

C33H54N2O7 (590.3931)

NAGlySer 18:4/10:0

C33H54N2O7 (590.3931)

Mgdg O-19:0_4:0

C32H62O9 (590.4394)

Mgdg O-20:0_3:0

C32H62O9 (590.4394)

Mgdg O-17:0_6:0

C32H62O9 (590.4394)

Mgdg O-14:0_9:0

C32H62O9 (590.4394)

Mgdg O-9:0_14:0

C32H62O9 (590.4394)

Mgdg O-21:0_2:0

C32H62O9 (590.4394)

Mgdg O-8:0_15:0

C32H62O9 (590.4394)

Mgdg O-16:0_7:0

C32H62O9 (590.4394)

Mgdg O-18:0_5:0

C32H62O9 (590.4394)

Mgdg O-15:0_8:0

C32H62O9 (590.4394)

Mgdg O-11:0_12:0

C32H62O9 (590.4394)

Mgdg O-10:0_13:0

C32H62O9 (590.4394)

Mgdg O-12:0_11:0

C32H62O9 (590.4394)

Mgdg O-13:0_10:0

C32H62O9 (590.4394)

PE-Cer 12:0;2O/17:1

C31H63N2O6P (590.4424)

PE-Cer 13:0;2O/16:1

C31H63N2O6P (590.4424)

PE-Cer 14:0;2O/15:1

C31H63N2O6P (590.4424)

PE-Cer 14:1;2O/15:0

C31H63N2O6P (590.4424)

PE-Cer 16:0;2O/13:1

C31H63N2O6P (590.4424)

PE-Cer 12:1;2O/17:0

C31H63N2O6P (590.4424)

PE-Cer 13:1;2O/16:0

C31H63N2O6P (590.4424)

PE-Cer 15:0;2O/14:1

C31H63N2O6P (590.4424)

PE-Cer 15:1;2O/14:0

C31H63N2O6P (590.4424)

PE-Cer 16:1;2O/13:0

C31H63N2O6P (590.4424)

PE-Cer 14:1;2O/14:1;O

C30H59N2O7P (590.406)

PE-Cer 12:1;2O/16:1;O

C30H59N2O7P (590.406)

PE-Cer 16:1;2O/12:1;O

C30H59N2O7P (590.406)

PE-Cer 15:1;2O/13:1;O

C30H59N2O7P (590.406)

PE-Cer 13:2;2O/15:0;O

C30H59N2O7P (590.406)

PE-Cer 15:2;2O/13:0;O

C30H59N2O7P (590.406)

PE-Cer 14:2;2O/14:0;O

C30H59N2O7P (590.406)

PE-Cer 13:1;2O/15:1;O

C30H59N2O7P (590.406)

PE-Cer 16:2;2O/12:0;O

C30H59N2O7P (590.406)

PE-Cer 12:0;2O/16:2;O

C30H59N2O7P (590.406)

PE-Cer 12:2;2O/16:0;O

C30H59N2O7P (590.406)

[(E)-3-hydroxy-2-(pentanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(hexanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(heptanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H58O4 (590.4335)

[(E)-2-acetamido-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(octanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(heptadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(propanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(octadecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(nonanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(butanoylamino)-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(hexadecanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(undecanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(tridecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(decanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(tetradecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-3-hydroxy-2-(pentadecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

PEtOH 12:0_14:1

C31H59O8P (590.3947)

PMeOH 12:0_15:1

C31H59O8P (590.3947)

PMeOH 14:0_13:1

C31H59O8P (590.3947)

PMeOH 13:0_14:1

C31H59O8P (590.3947)

PEtOH 13:0_13:1

C31H59O8P (590.3947)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C31H58O10 (590.403)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C31H58O10 (590.403)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C31H58O10 (590.403)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate

C31H58O10 (590.403)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C31H58O10 (590.403)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate

C31H58O10 (590.403)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C31H58O10 (590.403)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C31H58O10 (590.403)

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate

C31H58O10 (590.403)

[3-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] undecanoate

C31H58O10 (590.403)

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(E)-2-(dodecanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C31H59O8P (590.3947)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate

C31H59O8P (590.3947)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C31H59O8P (590.3947)

(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

C31H59O8P (590.3947)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C31H59O8P (590.3947)

(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

C31H59O8P (590.3947)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

C31H59O8P (590.3947)

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C31H59O8P (590.3947)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-heptadec-9-enoate

C31H59O8P (590.3947)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

C31H59O8P (590.3947)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate

C31H59O8P (590.3947)

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentadecanoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-9-enoate

C31H59O8P (590.3947)

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C38H54O5 (590.3971)

N-(dodecanoyl)-4E-tetradecasphingenine-1-phosphocholine

C31H63N2O6P (590.4424)

N-(decanoyl)-4E-hexadecasphingenine-1-phosphocholine

C31H63N2O6P (590.4424)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

C31H59O8P (590.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] octadec-17-enoate

C31H59O8P (590.3947)

[1-carboxy-3-[2-hydroxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO6+ (590.442)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate

C31H58O10 (590.403)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C31H59O8P (590.3947)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C31H59O8P (590.3947)

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C31H59O8P (590.3947)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-heptadec-9-enoate

C31H59O8P (590.3947)

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H56NO7+ (590.4057)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-7-enoate

C31H59O8P (590.3947)

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H63N2O6P (590.4424)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H56NO7+ (590.4057)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H56NO7+ (590.4057)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-6-enoate

C31H59O8P (590.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-4-enoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] octadec-17-enoate

C31H59O8P (590.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-9-enoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-6-enoate

C31H59O8P (590.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-7-enoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-13-enoate

C31H59O8P (590.3947)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate

C31H59O8P (590.3947)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-7-enoate

C31H59O8P (590.3947)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-9-enoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-11-enoate

C31H59O8P (590.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-octadec-13-enoate

C31H59O8P (590.3947)

[(2S)-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] undecanoate

C31H58O10 (590.403)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] dodecanoate

C31H58O10 (590.403)

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

C34H56NO7+ (590.4057)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-heptadec-9-enoate

C31H59O8P (590.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-4-enoate

C31H59O8P (590.3947)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

C31H59O8P (590.3947)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-pentadec-9-enoate

C31H59O8P (590.3947)

[3-[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H56NO7+ (590.4057)

[1-carboxy-3-[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C34H56NO7+ (590.4057)

2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

2-[[2-heptanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

[3-[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C34H56NO7+ (590.4057)

2-[carboxy-[2-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C34H56NO7+ (590.4057)

2-[[2-butanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

2-[[2-acetyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

2-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO7P+ (590.4185)

1,2-ditetradecanoyl-sn-glycerol-3-phosphate(2-)

C31H59O8P (590.3947)

A 1-acyl-2-tetradecanoyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of both phosphate OH groups of 1,2-ditetradecanoyl-sn-glycerol-3-phosphate(; major species at pH 7.3.

beta-sitosteryl ferulate

C39H58O4 (590.4335)

1-(9Z-tetradecenoyl)-2-tetradecanoyl-glycero-3-phosphate

C31H59O8P (590.3947)

1-dodecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate

C31H59O8P (590.3947)

1,2-Dimyrsitoylphosphatidate(2-)

C31H59O8P (590.3947)

A phosphatidate(2-) obtained by deprotonation of both phosphate OH groups of 1,2-dimyristoylphosphatidic acid; major species at pH 7.3.

ubiquinone-6

C39H58O4 (590.4335)

A ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.

Co(0:0)

C39H58O4 (590.4335)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 13:2/O-26:7

C39H58O4 (590.4335)

FAHFA 13:3/O-26:6

C39H58O4 (590.4335)

FAHFA 13:4/O-26:5

C39H58O4 (590.4335)

FAHFA 14:2/O-25:7

C39H58O4 (590.4335)

FAHFA 14:3/O-25:6

C39H58O4 (590.4335)

FAHFA 14:4/O-25:5

C39H58O4 (590.4335)

FAHFA 15:2/O-24:7

C39H58O4 (590.4335)

FAHFA 15:3/O-24:6

C39H58O4 (590.4335)

FAHFA 15:4/O-24:5

C39H58O4 (590.4335)

FAHFA 15:5/O-24:4

C39H58O4 (590.4335)

FAHFA 16:2/O-23:7

C39H58O4 (590.4335)

FAHFA 16:3/O-23:6

C39H58O4 (590.4335)

FAHFA 16:4/O-23:5

C39H58O4 (590.4335)

FAHFA 16:5/O-23:4

C39H58O4 (590.4335)

FAHFA 17:2/O-22:7

C39H58O4 (590.4335)

FAHFA 17:3/O-22:6

C39H58O4 (590.4335)

FAHFA 17:4/O-22:5

C39H58O4 (590.4335)

FAHFA 17:5/O-22:4

C39H58O4 (590.4335)

FAHFA 18:2/O-21:7

C39H58O4 (590.4335)

FAHFA 18:3/O-21:6

C39H58O4 (590.4335)

FAHFA 18:4/O-21:5

C39H58O4 (590.4335)

FAHFA 18:5/O-21:4

C39H58O4 (590.4335)

FAHFA 18:6/O-21:3

C39H58O4 (590.4335)

FAHFA 19:3/O-20:6

C39H58O4 (590.4335)

FAHFA 19:4/O-20:5

C39H58O4 (590.4335)

FAHFA 19:5/O-20:4

C39H58O4 (590.4335)

FAHFA 19:6/O-20:3

C39H58O4 (590.4335)

FAHFA 20:3/O-19:6

C39H58O4 (590.4335)

FAHFA 20:4/O-19:5

C39H58O4 (590.4335)

FAHFA 20:5/O-19:4

C39H58O4 (590.4335)

FAHFA 20:6/O-19:3

C39H58O4 (590.4335)

FAHFA 21:3/O-18:6

C39H58O4 (590.4335)

FAHFA 21:4/O-18:5

C39H58O4 (590.4335)

FAHFA 21:5/O-18:4

C39H58O4 (590.4335)

FAHFA 21:6/O-18:3

C39H58O4 (590.4335)

FAHFA 21:7/O-18:2

C39H58O4 (590.4335)

FAHFA 22:4/O-17:5

C39H58O4 (590.4335)

FAHFA 22:5/O-17:4

C39H58O4 (590.4335)

FAHFA 22:6/O-17:3

C39H58O4 (590.4335)

FAHFA 22:7/O-17:2

C39H58O4 (590.4335)

FAHFA 23:4/O-16:5

C39H58O4 (590.4335)

FAHFA 23:5/O-16:4

C39H58O4 (590.4335)

FAHFA 23:6/O-16:3

C39H58O4 (590.4335)

FAHFA 23:7/O-16:2

C39H58O4 (590.4335)

FAHFA 24:4/O-15:5

C39H58O4 (590.4335)

FAHFA 24:5/O-15:4

C39H58O4 (590.4335)

FAHFA 24:6/O-15:3

C39H58O4 (590.4335)

FAHFA 24:7/O-15:2

C39H58O4 (590.4335)

FAHFA 25:5/O-14:4

C39H58O4 (590.4335)

FAHFA 25:6/O-14:3

C39H58O4 (590.4335)

FAHFA 25:7/O-14:2

C39H58O4 (590.4335)

FAHFA 26:5/O-13:4

C39H58O4 (590.4335)

FAHFA 26:6/O-13:3

C39H58O4 (590.4335)

FAHFA 26:7/O-13:2

C39H58O4 (590.4335)

FAHFA 39:9;O

C39H58O4 (590.4335)

MGDG 10:0_12:0

C31H58O10 (590.403)

MGDG 11:0_11:0

C31H58O10 (590.403)

MGDG 22:0

C31H58O10 (590.403)

MGDG O-22:1;O

C31H58O10 (590.403)

MGDG O-23:0

C32H62O9 (590.4394)

MGMG 23:0

C32H62O9 (590.4394)

MGGA 22:0

C31H58O10 (590.403)

PA O-14:0/15:1

C32H63O7P (590.4311)

PA O-14:1/15:0

C32H63O7P (590.4311)

PA O-16:1/13:0

C32H63O7P (590.4311)

PA O-18:1/11:0

C32H63O7P (590.4311)

PA O-28:2;O

C31H59O8P (590.3947)

PA P-14:0/15:0

C32H63O7P (590.4311)

PA P-14:0/15:0 or PA O-14:1/15:0

C32H63O7P (590.4311)

PA P-16:0/13:0

C32H63O7P (590.4311)

PA P-16:0/13:0 or PA O-16:1/13:0

C32H63O7P (590.4311)

PA P-18:0/11:0

C32H63O7P (590.4311)

PA P-18:0/11:0 or PA O-18:1/11:0

C32H63O7P (590.4311)

PA P-20:0/8:1;O

C31H59O8P (590.3947)

PA P-29:0

C32H63O7P (590.4311)

PA P-29:0 or PA O-29:1

C32H63O7P (590.4311)

PA 10:0_18:1

C31H59O8P (590.3947)

PA 11:0_17:1

C31H59O8P (590.3947)

PA 12:0_16:1

C31H59O8P (590.3947)

PA 13:0_15:1

C31H59O8P (590.3947)

PA 14:0_14:1

C31H59O8P (590.3947)

PA 24:0/4:1

C31H59O8P (590.3947)

PA 24:1/4:0

C31H59O8P (590.3947)

PA 26:1/2:0

C31H59O8P (590.3947)

LPEth 27:1

C32H63O7P (590.4311)

LPM 28:1

C32H63O7P (590.4311)

PEth 26:1

C31H59O8P (590.3947)

PM 27:1

C31H59O8P (590.3947)

CerPE 14:0;O2/15:1

C31H63N2O6P (590.4424)

CerPE 14:1;O2/15:0

C31H63N2O6P (590.4424)

CerPE 14:2;O2/14:0;O

C30H59N2O7P (590.406)

CerPE 15:0;O2/14:1

C31H63N2O6P (590.4424)

CerPE 15:1;O2/14:0

C31H63N2O6P (590.4424)

CerPE 15:2;O2/13:0;O

C30H59N2O7P (590.406)

CerPE 16:1;O2/13:0

C31H63N2O6P (590.4424)

CerPE 16:2;O2/12:0;O

C30H59N2O7P (590.406)

CerPE 17:1;O2/12:0

C31H63N2O6P (590.4424)

CerPE 17:2;O2/11:0;O

C30H59N2O7P (590.406)

CerPE 18:1;O2/11:0

C31H63N2O6P (590.4424)

CerPE 18:2;O2/10:0;O

C30H59N2O7P (590.406)

CerPE 19:1;O2/10:0

C31H63N2O6P (590.4424)

CerPE 28:2;O2;O

C30H59N2O7P (590.406)

CerPE 29:1;O2

C31H63N2O6P (590.4424)

SM 14:1;O2/12:0

C31H63N2O6P (590.4424)

SM 14:2;O2/11:0;O

C30H59N2O7P (590.406)

SM 15:1;O2/11:0

C31H63N2O6P (590.4424)

SM 15:2;O2/10:0;O

C30H59N2O7P (590.406)

SM 16:1;O2/10:0

C31H63N2O6P (590.4424)

SM 25:2;O2;O

C30H59N2O7P (590.406)

SM 26:1;O2

C31H63N2O6P (590.4424)

ST 29:1;O;GlcA

C35H58O7 (590.4182)

ST 29:2;O2;Hex

C35H58O7 (590.4182)

(1s,3ar,5ar,5br,7ar,9s,11ar,11br,13as,13br)-1-isopropyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

(2r,3r,4r,5r)-2-{[(1s,2s,3as,3br,4s,7s,9as,9bs,11as)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2s)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

C39H58O4 (590.4335)

10-(3-methoxybenzoyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C38H54O5 (590.3971)

21α-hydroxyserrat-14-en-3β-ylp-dihydrocoumarate

C39H58O4 (590.4335)

{"Ingredient_id": "HBIN003545","Ingredient_name": "21\u03b1-hydroxyserrat-14-en-3\u03b2-ylp-dihydrocoumarate","Alias": "NA","Ingredient_formula": "C39H58O4","Ingredient_Smile": "CC1(C2CCC3(CC4=CCC5C(C(CCC5(C4CCC3C2(CCC1OC(=O)CCC6=CC=C(C=C6)O)C)C)O)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10706","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,3r,4s,5r,6r)-2-{[(1r,3ar,5as,7s,9as,11ar)-1-[(2s,3r,5r)-5-ethyl-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-(3-methoxybenzoyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C38H54O5 (590.3971)

(1r,1's,5s,5's,8's,9s,9's,11'r,14r,14's,15s,16s,17'r,18'r,19r,21s)-5,5',7-trimethyl-20-oxa-7,7'-diazaspiro[heptacyclo[13.6.1.1⁵,⁹.0¹,¹².0⁴,¹¹.0¹⁴,¹⁶.0¹⁶,²¹]tricosane-19,12'-hexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane]-4(11),6',12-triene

C41H54N2O (590.4236)

(2s,3r,4s,5r)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

(5e,7r,8s,9s,11e,13e,15s,16s)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O7 (590.4182)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-hydroxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)

[9-hydroxy-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

C38H54O5 (590.3971)

(2s,3r,4s,5r)-2-{[(1r,3as,3br,4s,7s,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

16-[4-(2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,5,7,9,11,15-hexamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O7 (590.4182)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H58O7 (590.4182)

(2s,3r,4s,5r)-2-{[(1r,2s,3as,3br,4s,7s,9as,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

2-{[2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

n-[14-(benzoyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-9-en-6-yl]-2-methylpropanimidic acid

C37H54N2O4 (590.4083)

(2s,3r,4s,5s)-2-{[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-3,4,5-triol

C35H58O7 (590.4182)

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

(3e,5e,7e,9e,11e,13e,15e,17e)-10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

C43H58O (590.4487)

1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H58O7 (590.4182)

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(4-hydroxyphenyl)propanoate

C39H58O4 (590.4335)

[(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-9-hydroxy-3a-(methoxycarbonyl)-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-5a-yl]methyl benzoate

C38H54O5 (590.3971)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)

(1s,2s,3as,3bs,5ar,6r,7s,9r,9as,9bs,10r,11as)-9-(acetyloxy)-1-[(1s)-1-(dimethylamino)ethyl]-2,6-dihydroxy-7-[(3s)-3-isopropyl-2-oxoazetidin-1-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-10-yl acetate

C33H54N2O7 (590.3931)

1-(2-hydroxypropan-2-yl)-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O4 (590.4335)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-2-ethoxy-1-hydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)

10,14,18,22-tetramethyl-5-[(1e,3e,5e,7e)-4,8,12-trimethyltrideca-1,3,5,7,11-pentaen-1-yl]tricosa-3,5,7,9,11,13,15,17,21-nonaen-2-one

C43H58O (590.4487)

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H58O7 (590.4182)

1-[5-(2-ethoxy-1-hydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C35H58O7 (590.4182)

2-{[1-(5-hydroxy-5-isopropylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)

2-{[1-(5-ethyl-3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O7 (590.4182)

6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H58O7 (590.4182)